Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

Abstract

Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespecified cardiovascular events in patients with a history of myocardial infarction or unstable angina who had a broad range of initial cholesterol levels.

Keywords

PravastatinMedicineMyocardial infarctionInternal medicineRelative riskCardiologyAnginaPlaceboConfidence intervalUnstable anginaStroke (engine)Incidence (geometry)Cholesterol

Affiliated Institutions

The University of Sydney AU

Related Publications

Decline in Cardiovascular Mortality

George A. Mensah , Gina S. Wei , Paul D. Sorlie +8 more

If the control of infectious diseases was the public health success story of the first half of the 20th century, then the decline in mortality from coronary heart disease and st...

2017 Circulation Research 785 citations

Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis

Enrico Ammirati , Manlio Cipriani , Claudio Moro +35 more

Background: There is controversy about the outcome of patients with acute myocarditis (AM), and data are lacking on how patients admitted with suspected AM are managed. We repor...

2018 Circulation 396 citations

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

Klas Malmberg , Anna Norhammar , Hans Wedel +1 more

Background —The Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study addressed prognostic factors and the effects of concomitant treatment and gly...

1999 Circulation 851 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

Salim Yusuf , Peter Sleight , Janice Pogue +3 more

Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or ...

2000 New England Journal of Medicine 8597 citations

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

Costas Thomopoulos , Gianfranco Parati , Alberto Zanchetti

Meta-analyses of all BP-lowering RCTs involving hypertensive patients provide precise estimates of benefits (larger for stroke and heart failure, but also significant for CHD an...

2014 Journal of Hypertension 364 citations

Publication Info

Year: 1998
Type: article
Volume: 339
Issue: 19
Pages: 1349-1357
Citations: 5274
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

5274

OpenAlex

Cite This

APA Style

                            
                                
                                    A. Tonkin, 
                                
                                    Philip E Alyward, 
                                
                                    David Colquhoun
                                
                                et al.
                            
                            (1998). 
                            Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels. 
                            New England Journal of Medicine
                            , 339
                            (19)
                            , 1349-1357.
                            https://doi.org/10.1056/nejm199811053391902
                        

Identifiers

DOI: 10.1056/nejm199811053391902